Quoin Pharmaceuticals
QNRX | NASDAQ
$3.56
-$0.14 (-3.78%)
At close: Nov 16, 2026, 4:00 PM ET
$3.69
+$0.13 (+3.65%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-3.78%
(1D)No price chart data available for 1D timeframe.
Rating
39.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #550/1021 (Top 54%)
Key Statistics
Market Data
Market Cap $17.95M
1D Range
3.56 3.79
52W Range
3.25 22.30
Valuation (TTM)
PE -0.39
PB 0.63
EV/EBITDA -0.52
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $17.00
Cash Flow
FCF Yield 239008.0%
SBC Adj. FCF Yield 252871.3%
SBC Impact -5.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 126.8% |
17.5%
FCF 3Y | 5Y 150.1% |
100.1%
Returns
ROA -56.6%
ROE -144.4%
ROIC -67.2%
Financial Health
Net Cash
$10.1M
Current Ratio 7.20
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QR...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Aug 1, 2016
Website quoinpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove QNRX